Nobuki Hayakawa
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study.
Journal: Cureus
Published: October 30, 2025
Cytomegalovirus Occurrence and Time-to-onset Analysis Under Bendamustine With Anti-CD20 Antibodies Using the JADER Database.
Journal: In vivo (Athens, Greece)
Published: November 22, 2023
Changes in Serum Immunoglobulin G4 Levels in Patients with Newly Diagnosed Graves' Disease.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: September 21, 2018
The efficacy and safety of activated vitamin D for CKD-MBD
Journal: Clinical calcium
Published: August 27, 2016
Updates on Lifestyle-Related Diseases and Bone Metabolism. Effects of therapeutic agents for lifestyle-related diseases on osteoporosis
Journal: Clinical calcium
Published: October 31, 2014
Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
Journal: Heart and vessels
Published: October 30, 2013
Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis
Journal: Clinical calcium
Published: September 04, 2013
Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case.
Journal: Surgery today
Published: July 24, 2013
Diabetes mellitus and osteoporosis. Effect of antidiabetic medicine on osteoporotic fracture
Journal: Clinical calcium
Published: August 31, 2012
Relative levels of the inflammatory cytokine TNFα and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves' disease.
Journal: Thyroid : official journal of the American Thyroid Association
Published: April 20, 2012
Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease.
Journal: Journal of bone and mineral metabolism
Published: January 29, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026